| Primary |
| Anaesthesia |
22.4% |
| General Anaesthesia |
12.9% |
| Induction Of Anaesthesia |
11.2% |
| Drug Use For Unknown Indication |
7.6% |
| Maintenance Of Anaesthesia |
7.1% |
| Schizophrenia |
5.9% |
| Hypertension |
4.1% |
| Maternal Drugs Affecting Foetus |
3.5% |
| Surgery |
3.5% |
| Analgesic Therapy |
2.9% |
| Depression |
2.4% |
| Head And Neck Cancer |
2.4% |
| Maternal Exposure During Pregnancy |
2.4% |
| Antibiotic Prophylaxis |
1.8% |
| Constipation |
1.8% |
| Endometrial Ablation |
1.8% |
| Infection |
1.8% |
| Product Used For Unknown Indication |
1.8% |
| Pyrexia |
1.8% |
| Anaesthesia Procedure |
1.2% |
|
| Hypotension |
12.8% |
| Procedural Complication |
10.3% |
| Drug Exposure During Pregnancy |
7.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
7.7% |
| Pain |
7.7% |
| Accidental Overdose |
5.1% |
| Anaphylactic Reaction |
5.1% |
| Cardiac Arrest |
5.1% |
| Drug Ineffective |
5.1% |
| Sinus Arrest |
5.1% |
| Urine Output Decreased |
5.1% |
| Angle Closure Glaucoma |
2.6% |
| Apnoea |
2.6% |
| Bile Duct Cancer |
2.6% |
| Bundle Branch Block |
2.6% |
| Caesarean Section |
2.6% |
| Circulatory Collapse |
2.6% |
| Convulsion |
2.6% |
| Heart Rate Decreased |
2.6% |
| Humerus Fracture |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
41.4% |
| Anaesthesia |
8.7% |
| General Anaesthesia |
6.6% |
| Induction Of Anaesthesia |
6.3% |
| Drug Use For Unknown Indication |
5.2% |
| Ill-defined Disorder |
4.8% |
| Analgesic Therapy |
3.7% |
| Premedication |
2.4% |
| Constipation |
2.1% |
| Infection |
2.1% |
| Electrolyte Substitution Therapy |
1.9% |
| Foetal Exposure During Pregnancy |
1.9% |
| Antibiotic Prophylaxis |
1.8% |
| Pyrexia |
1.8% |
| Schizophrenia |
1.7% |
| Hypertension |
1.6% |
| Induction And Maintenance Of Anaesthesia |
1.6% |
| Pain |
1.6% |
| Maintenance Of Anaesthesia |
1.5% |
| Anaesthesia Procedure |
1.3% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
13.2% |
| Anaphylactic Shock |
10.5% |
| Renal Failure Acute |
10.0% |
| Toxic Epidermal Necrolysis |
8.7% |
| Circulatory Collapse |
5.5% |
| Tachycardia |
5.5% |
| Generalised Erythema |
5.0% |
| Shock |
4.6% |
| Unwanted Awareness During Anaesthesia |
4.6% |
| Coma |
3.2% |
| Convulsion |
3.2% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
3.2% |
| Hypotension |
3.2% |
| Urticaria |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Anaphylactoid Shock |
2.7% |
| Cardiac Failure |
2.7% |
| Stevens-johnson Syndrome |
2.7% |
| Thrombocytopenia |
2.7% |
| Cerebral Haematoma |
2.3% |
|
| Concomitant |
| General Anaesthesia |
11.3% |
| Analgesic Therapy |
10.6% |
| Anaesthesia |
8.8% |
| Induction Of Anaesthesia |
8.6% |
| Prophylaxis |
7.9% |
| Anaesthesia Procedure |
6.0% |
| Product Used For Unknown Indication |
6.0% |
| Drug Use For Unknown Indication |
5.9% |
| Sedation |
5.1% |
| Hypertension |
4.2% |
| Maintenance Of Anaesthesia |
3.5% |
| Postoperative Care |
3.1% |
| Cancer Pain |
2.6% |
| Premedication |
2.6% |
| Infection Prophylaxis |
2.4% |
| Neuromuscular Blocking Therapy |
2.4% |
| Antibiotic Prophylaxis |
2.3% |
| Induction And Maintenance Of Anaesthesia |
2.3% |
| Surgery |
2.3% |
| Haemostasis |
2.0% |
|
| Anaphylactic Shock |
13.3% |
| Shock |
9.4% |
| Rhabdomyolysis |
8.6% |
| Tachycardia |
8.6% |
| Delayed Recovery From Anaesthesia |
5.5% |
| Intentional Drug Misuse |
4.7% |
| Urticaria |
4.7% |
| Cardiac Arrest |
3.9% |
| Multi-organ Failure |
3.9% |
| Pyrexia |
3.9% |
| Skin Test Positive |
3.9% |
| Thrombocytopenia |
3.9% |
| Tongue Oedema |
3.9% |
| Vomiting |
3.9% |
| Cytolytic Hepatitis |
3.1% |
| Depressed Level Of Consciousness |
3.1% |
| Electrocardiogram St Segment Depression |
3.1% |
| Loss Of Consciousness |
3.1% |
| Shock Haemorrhagic |
3.1% |
| Ileus |
2.3% |
|
| Interacting |
| General Anaesthesia |
46.4% |
| Product Used For Unknown Indication |
21.4% |
| Hypertension |
17.9% |
| Bunion Operation |
7.1% |
| Anaesthesia |
3.6% |
| Aortic Valve Replacement |
3.6% |
|
| Drug Interaction |
60.0% |
| Gait Disturbance |
20.0% |
| Salivary Gland Neoplasm |
20.0% |
|
